Paying users zone. Data is hidden behind 
.
Get 1-month access to Pfizer Inc. for $19.99, or
get full access to the entire website for at least 3 months from $49.99.
We accept:
This is a one-time payment. There is no automatic renewal.
Pfizer Inc. (PFE)
Price to Earnings (P/E)
since 2005
Low level of difficulty
Calculation
Pfizer Inc., P/E, long-term trends, calculation
| P/E | = | Share price1, 2, 3 | ÷ | Earnings per share1 (EPS) | EPS1 | = | Net income attributable to Pfizer Inc. common shareholders1 (in millions) | ÷ | No. shares of common stock outstanding2 | |
|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2017 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2016 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2015 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2014 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2013 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2012 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2011 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2010 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2009 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2008 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2007 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2006 | |
= | |
÷ | |
|
= | |
÷ | |
| Dec 31, 2005 | |
= | |
÷ | |
|
= | |
÷ | |
Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-28), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).
1 US$
2 Data adjusted for splits and stock dividends.
3 Closing price as at the filing date of Pfizer Inc.’s Annual Report.
Comparison to Competitors
Pfizer Inc., P/E, long-term trends, comparison to competitors
| Pfizer Inc. | Abbott Laboratories | AbbVie Inc. | Allergan PLC | Amgen Inc. | Biogen Inc. | Bristol-Myers Squibb Co. | Celgene Corp. | Eli Lilly & Co. | Gilead Sciences Inc. | Johnson & Johnson | Merck & Co. Inc. | Regeneron Pharmaceuticals Inc. | |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Dec 31, 2018 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2017 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2016 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2015 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2014 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2013 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2012 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2011 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2010 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2009 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2008 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2007 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2006 | |
|
|
|
|
|
|
|
|
|
|
|
|
| Dec 31, 2005 | |
|
|
|
|
|
|
|
|
|
|
|
|
Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-28), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).
Comparison to Sector (Pharmaceuticals & Biotechnology)
Pfizer Inc., P/E, long-term trends, comparison to sector (pharmaceuticals & biotechnology)
| Pfizer Inc. | Pharmaceuticals & Biotechnology | |
|---|---|---|
| Dec 31, 2018 | |
|
| Dec 31, 2017 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2005 | |
|
Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-28), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).
Comparison to Industry (Health Care)
Pfizer Inc., P/E, long-term trends, comparison to industry (health care)
| Pfizer Inc. | Health Care | |
|---|---|---|
| Dec 31, 2018 | |
|
| Dec 31, 2017 | |
|
| Dec 31, 2016 | |
|
| Dec 31, 2015 | |
|
| Dec 31, 2014 | |
|
| Dec 31, 2013 | |
|
| Dec 31, 2012 | |
|
| Dec 31, 2011 | |
|
| Dec 31, 2010 | |
|
| Dec 31, 2009 | |
|
| Dec 31, 2008 | |
|
| Dec 31, 2007 | |
|
| Dec 31, 2006 | |
|
| Dec 31, 2005 | |
|
Based on: 10-K (filing date: 2019-02-28), 10-K (filing date: 2018-02-22), 10-K (filing date: 2017-02-23), 10-K (filing date: 2016-02-29), 10-K (filing date: 2015-02-27), 10-K (filing date: 2014-02-28), 10-K (filing date: 2013-02-28), 10-K (filing date: 2012-02-28), 10-K (filing date: 2011-02-28), 10-K (filing date: 2010-02-26), 10-K (filing date: 2009-02-27), 10-K (filing date: 2008-02-29), 10-K (filing date: 2007-03-01), 10-K (filing date: 2006-03-01).